[Effect of prodigiozan on the course of burns in dogs].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002056:Burns / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D002701:Chloramphenicol / Q000494:pharmacology; D002751:Chlortetracycline / Q000494:pharmacology; D004285:Dogs; D004352:Drug Resistance, Microbial; D015643:Erythromycin Ethylsuccinate / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D008111:Liver Function Tests; D011113:Polymyxins / Q000494:pharmacology; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D018805:Sepsis / Q000517:prevention & control; D012706:Serratia marcescens; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D014946:Wound Infection / Q000382:microbiology
D000970:Antineoplastic Agents; D011113:Polymyxins; D011135:Polysaccharides, Bacterial; D015643:Erythromycin Ethylsuccinate; D002701:Chloramphenicol; D002751:Chlortetracycline
Vliianie prodigiozana na techenie ozhogovoĭ bolezni u sobak.